The Alzheimer’s Prevention Initiative Composite Cognitive Test: a practical measure for tracking cognitive decline in preclinical Alzheimer’s disease

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1758-9193
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
The Alzheimer’s Prevention Initiative Composite Cognitive Test: a practical measure for tracking cognitive decline in preclinical Alzheimer’s disease ; volume:12 ; number:1 ; day:27 ; month:5 ; year:2020 ; pages:1-11 ; date:12.2020
Alzheimer's research & therapy ; 12, Heft 1 (27.5.2020), 1-11, 12.2020

Urheber
Langbaum, Jessica B.
Ellison, Noel N.
Caputo, Angelika
Thomas, Ronald G.
Langlois, Carolyn
Riviere, Marie-Emmanuelle
Graf, Ana
Lopez Lopez, Cristina
Reiman, Eric M.
Tariot, Pierre N.
Hendrix, Suzanne B.
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1186/s13195-020-00633-2
URN
urn:nbn:de:101:1-2020080101380935182982
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 11:01 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Langbaum, Jessica B.
  • Ellison, Noel N.
  • Caputo, Angelika
  • Thomas, Ronald G.
  • Langlois, Carolyn
  • Riviere, Marie-Emmanuelle
  • Graf, Ana
  • Lopez Lopez, Cristina
  • Reiman, Eric M.
  • Tariot, Pierre N.
  • Hendrix, Suzanne B.
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease

Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease

Awareness of Olfactory Dysfunction in Subjective Cognitive Decline, Mild Cognitive Decline, and Alzheimer’s Disease

Awareness of Olfactory Dysfunction in Subjective Cognitive Decline, Mild Cognitive Decline, and Alzheimer’s Disease

Progressive cervical cord atrophy parallels cognitive decline in Alzheimer’s disease

Progressive cervical cord atrophy parallels cognitive decline in Alzheimer’s disease

Application of Digital Cognitive Biomarkers for Alzheimer’s Disease: Identifying Cognitive Process Changes and Impending Cognitive Decline

Application of Digital Cognitive Biomarkers for Alzheimer’s Disease: Identifying Cognitive Process Changes and Impending Cognitive Decline

Will cognitive mapping hinder Alzheimer’s Disease?

Will cognitive mapping hinder Alzheimer’s Disease?

Impact of atrial fibrillation on the cognitive decline in Alzheimer’s disease

Impact of atrial fibrillation on the cognitive decline in Alzheimer’s disease

Cognitive Blackouts in Mild Cognitive Impairment and Alzheimer’s Dementia

Cognitive Blackouts in Mild Cognitive Impairment and Alzheimer’s Dementia

Longitudinal Cognitive Decline in Patients With Mild Cognitive Impairment or Dementia Due to Alzheimer’s Disease

Longitudinal Cognitive Decline in Patients With Mild Cognitive Impairment or Dementia Due to Alzheimer’s Disease

Cerebrospinal Fluid Cortisol and Dehydroepiandrosterone Sulfate, Alzheimer’s Disease Pathology, and Cognitive Decline

Cerebrospinal Fluid Cortisol and Dehydroepiandrosterone Sulfate, Alzheimer’s Disease Pathology, and Cognitive Decline

Lewy body pathology exacerbates brain hypometabolism and cognitive decline in Alzheimer’s disease

Lewy body pathology exacerbates brain hypometabolism and cognitive decline in Alzheimer’s disease

Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease

Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease

Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer’s dementia

Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer’s dementia

Verbundene Objekte